IncompleteSLA andSLAComplianceMedicallyacceptedindicationOveractiveBladder(OAB)Non-FormularyGridStep-TherapyPDPMAPDDefaultduration -12/31/13IncompleteNotesStrength ofrecommendationis III andevidence isinconclusive orineffectiveBEERsListIncompleteTransitionalOverrideUrgencyand casetypeMA-OnlySharedVerbiageNon-FormularyBronchospasmrelated toCOPDNF, ST,TCSE,QLDiagnosisReviewDecisionNotesStrength ofrecommendationis class I, IIa, IIbwith any efficacyor III if evidencefavor efficacyPARequiredand BvsDNot FDA-approvedIncompleteSLA andSLAComplianceMedicallyacceptedindicationOveractiveBladder(OAB)Non-FormularyGridStep-TherapyPDPMAPDDefaultduration -12/31/13IncompleteNotesStrength ofrecommendationis III andevidence isinconclusive orineffectiveBEERsListIncompleteTransitionalOverrideUrgencyand casetypeMA-OnlySharedVerbiageNon-FormularyBronchospasmrelated toCOPDNF, ST,TCSE,QLDiagnosisReviewDecisionNotesStrength ofrecommendationis class I, IIa, IIbwith any efficacyor III if evidencefavor efficacyPARequiredand BvsDNot FDA-approved

Medicare Overview/Incomplete/NF/ST/Off-Label - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Incomplete SLA and SLA Compliance
  2. Medically accepted indication
  3. Overactive Bladder (OAB)
  4. Non-Formulary Grid
  5. Step-Therapy
  6. PDP
  7. MAPD
  8. Default duration - 12/31/13
  9. Incomplete Notes
  10. Strength of recommendation is III and evidence is inconclusive or ineffective
  11. BEERs List
  12. Incomplete
  13. Transitional Override
  14. Urgency and case type
  15. MA-Only
  16. Shared Verbiage
  17. Non-Formulary
  18. Bronchospasm related to COPD
  19. NF, ST, TCSE, QL
  20. Diagnosis Review
  21. Decision Notes
  22. Strength of recommendation is class I, IIa, IIb with any efficacy or III if evidence favor efficacy
  23. PA Required and BvsD
  24. Not FDA-approved